Five insights:
1. Dr. Petraglia specializes in spine and brain surgery, with added experience in sports-related injuries.
2. Geocann created the CMO role to provide medical leadership in an industry which is still relatively new.
3. Dr. Petraglia will provide his experience in the clinical study design, review of the latest cannabis developments and how they relate to pain, sleep, anxiety and other conditions.
4. He is a neurosurgeon at Rochester Regional Health In New York and the acting executive director of the hospital’s concussion program.
5. Dr. Petraglia is a participating member of the American Association of Neurological Surgeons and Congress of Neurological Surgeons and co-authored the Handbook of Neurological Sports Medicine: Concussion and Other Nervous System Injuries in the Athlete.
Geocann focuses on fusing clinically researched cannabinoids with innovative technology to improve therapeutic performance.
“The difference these products can make in a patient’s recovery is simply unmatched,” said Dr. Petraglia.
More articles on biologics:
The highest value bone graft substitute for spine surgery: 5 findings
AlloSource honors Steadman Clinic’s Dr. Matthew Provencher — 3 insights
Timothy Wright joins MiMedx as CEO — 3 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
